Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma

European Journal of Surgical Oncology

Volumn 32, Issue 9, 2006, Pages 948-953

  Yan, T D ^a   Yoo, D ^a   Sugarbaker, P H ^a  

^a WASHINGTON CANCER INSTITUTE   (United States)

Author keywords

Asbestos; Cytoreductive surgery; Intraperitoneal chemotherapy; Lymph node metastasis; Peritoneal mesothelioma; Peritonectomy

Indexed keywords

CISPLATIN; DOXORUBICIN; PACLITAXEL;

ADULT; AGED; ARTICLE; BLEEDING; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; EPITHELIUM; FEMALE; HISTOLOGY; HUMAN; INFORMATION PROCESSING; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT MESOTHELIOMA; MULTIVARIATE ANALYSIS; PERFORMANCE; PERITONEUM MESOTHELIOMA; PEROPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TISSUE TYPES; UNITED STATES; UNIVARIATE ANALYSIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MESOTHELIOMA; MIDDLE AGED; PERITONEAL NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 33750322184     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.05.009     Document Type: Article

References (30)

1. McDonald A.D., and MacDonald J.C. Epidemiology of malignant mesothelioma. In: Antman K., and Aisner J. (Eds). Asbestos-related malignancy (1987), Grune & Stratton, Orland, FL 31-35
2. Asensio J.A., Goldblatt P., and Thomford N.R. Primary malignant peritoneal mesothelioma. A report of seven cases and a review of the literature. Arch Surg 125 (1990) 477-481
3. Sridhar K.S., Doria R., Raub Jr. W.A., Thurer R.J., and Saldana M. New strategies are needed in diffuse malignant mesothelioma. Cancer 70 (1992) 2969-2979
4. Chailleux E., Dabouis G., Pioche D., et al. Prognostic factors in diffuse malignant pleural mesothelioma. A study of 167 patients. Chest 93 (1988) 159-162
5. Antman K., Shemin R., Ryan L., et al. Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985. J Clin Oncol 6 (1988) 147-153
6. Markman M., and Kelsen D. Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma. J Cancer Res Clin Oncol 118 (1992) 547-550
7. Yates D.H., Corrin B., Stidolph P.N., and Browne K. Malignant mesothelioma in south east England: clinicopathological experience of 272 cases. Thorax 52 (1997) 507-512
8. Neumann V., Muller K.M., and Fischer M. Peritoneal mesothelioma - incidence and etiology. Pathologe 20 (1999) 169-176
9. Eltabbakh G.H., Piver M.S., Hempling R.E., Recio F.O., and Intengen M.E. Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma. J Surg Oncol 70 (1999) 6-12
10. Sebbag G., Yan H., Shmookler B.M., Chang D., and Sugarbaker P.H. Results of treatment of 33 patients with peritoneal mesothelioma. Br J Surg 87 (2000) 1587-1593
11. Sugarbaker P.H., Acherman Y.I.Z., Gonzalez-Moreno S., et al. Diagnosis and treatment of peritoneal mesothelioma: Washington Cancer Institute Experience. Semin Oncol 29 1 (2002) 51-61
12. Sugarbaker P.H., Welch L.S., Mohamed F., and Glehen O. A review of peritoneal mesothelioma at the Washington Cancer Institute. Surg Oncol Clin N Am 12 3 (2003) 605-621
13. Park B.J., Alexander H.R., Libutti S.K., et al. Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion (CHPP). Ann Surg Oncol 6 6 (1999) 582-590
14. Feldman A.L., Libutti S.K., Pingpank J.F., et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol 21 (2003) 4560-4567
15. Nonaka D., Kusamura S., Baratti D., et al. Diffuse malignant mesothelioma of peritoneum. Cancer 104 (2005) 2181-2188
16. Sugarbaker P.H. Peritonectomy procedures. Ann Surg 221 (1995) 29-42
17. Glehen O., and Gilly F.N. Quantitative prognostic indicators of peritoneal surface malignancy: carcinomatosis, sarcomatosis, and peritoneal mesothelioma. Surg Oncol Clin N Am 12 (2003) 649-671
18. Sugarbaker P.H. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome. Lancet Oncol 7 (2006) 69-76
19. Sugarbaker P.H., Graves T., De Bruijn E.A., et al. Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. Cancer Res 50 (1990) 5790-5794
20. Katz M., and Barone R. The rationale of perioperative intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies. Surg Oncol Clin N Am 12 (2003) 673-688
21. Riera J.R., Astengo-Osuna C., Longmate J.A., and Battifora H. The immunohistochemical diagnostic panel for epithelial mesothelioma. A reevaluation after heat-induced epitope retrieval. Am J Surg Pathol 21 (1997) 1409-1419
22. Ordonez N.G. Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma. Am J Surg Pathol 22 (1998) 1215-1221
23. Ordonez N.G. Role of immunohistochemistry in distinguishing epithelial peritoneal mesothelioma from peritoneal and ovarian serous carcinomas. Am J Surg Pathol 22 (1998) 1203-1214
24. Carmignani C.P., Sugarbaker T.A., Bromley C.M., and Sugarbaker P.H. Intraperitoneal cancer dissemination: mechanisms of the pattern of spread. Cancer Metastasis Rev 22 (2003) 465-472
25. Meyer M.A. Distribution of intraabdominal malignant seeding: dependency on dynamics of flow of ascitic fluid. Am J Roentgenol Radium Ther Nucl Med 119 (1973) 198-206
26. Autio V. The spread of intraperitoneal infection. Acta Chir Scand 321 (1964) 5-31
27. Abu-Hijleh M.F., Habbal O.A., and Moqattash S.T. The role of the diaphragm in lymphatic absorption from the peritoneal cavity. J Anat 186 (1995) 453-467
28. Takahashi T., Shimotsuma M., Hagiwara A., Sawai K., and Yamaguchi T. Role of peritoneal lymphatics for peritoneal metastasis and chemotherapy with mitomycin C bound to activated carbon particles. Acta Chir Austriaca 2 (1995) 76-78
29. Eltabbakh G.H., and Mount S.L. Lymphatic spread among women with primary peritoneal carcinoma. J Surg Oncol 81 (2002) 126-131
30. Gonzalez M.S., Brun E.A., and Sugarbaker P.H. Lymph node metastasis in epithelial malignancies of the appendix with peritoneal dissemination does not reduce survival in patients treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy. Ann Surg Oncol 12 (2005) 72-80